
@NSTumorSectioni
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
The Official Twitter profile of the AANS/CNS Joint Section on Tumors
Joined January 2017
- Tweets1.7K
- Following557
- Followers6.6K
- Likes2.3K
Join the AANS/CNS Joint Section on Tumors at #CNS2026 in Washington, D.C. for two days of connection, mentorship, and a little friendly competition.
#Neurosurgery #NeuroOncology #CNS2026
Interested in a career in neurosurgical oncology?
Join the AANS/CNS Joint Section on Tumors Resident Subcommittee at #CNS2026 for our Fellowship Meet & Greet.
📅 Nov 1 | 8:15–10:45 PM
📍 Flight Club DC
🎟️ FREE registration
Register: rebrand.ly/TSCNS2026
Applying for a Neurosurgical Oncology Fellowship beginning July 2028?
Save these key dates for the 2027 NRMP Match cycle and explore the Tumor Section’s resources for applicants.
📘 Neurosurgical Oncology Match Guide:
tumorsection.org/neuro-oncol…
Join the AANS/CNS Joint Section on Tumors at #CNS2026 in Washington, D.C. for two days of connection, mentorship, and a little friendly competition.
#Neurosurgery #NeuroOncology #CNS2026
Join the AANS/CNS Joint Section on Tumors at #CNS2026 in Washington, D.C. for two days of connection, mentorship, and a little friendly competition.
#Neurosurgery #NeuroOncology #CNS2026
Interested in a career in neurosurgical oncology?
Join the AANS/CNS Joint Section on Tumors Resident Subcommittee at #CNS2026 for our Fellowship Meet & Greet.
📅 Nov 1 | 8:15–10:45 PM
📍 Flight Club DC
🎟️ FREE registration
Register: rebrand.ly/TSCNS2026
🚨 TUMOR WARS III: Neuro-Onc Jeopardy 🧠⚡
The showdown returns! Med students, residents & fellows will compete in a fast-paced neuro-onc Jeopardy battle.
👉 Register: forms.gle/pY27qDL6pVb9XsMo9
⚡ How should we approach seizures caused by brain tumors?
Join Dr. Nitin Tandon for a discussion on the etiology of tumoral epilepsy and how seizure biology, tumor location, and surgical strategy influence management.
📅 September 16 | 3:30 PM CST
🔗 rebrand.ly/nt091626
Join Dr. Gabriel Zada for a discussion on endoscopic, keyhole, and port-based approaches—and how these strategies are expanding surgical options in neuro-oncology.
📅 September 9 | 3:30 PM CST
🔗 rebrand.ly/gz090926
NS Tumor Section retweeted
Are you a WINS member presenting at CNS 2026? Submit your presentation details today to be highlighted on WINS social media!
Researchers have grown brain organoids that mirror the development of the human brain for more than five years
go.nature.com/4xTYiDH
NS Tumor Section retweeted
Replying to @TheJNS
@TheJNS is now accepting papers for the May 2027 issue of Neurosurgical Focus on Advocacy & Policy! Don't delay, submit today! Submissions are due no later than Nov. 1.
For more info about the topic and/or to submit your paper, visit the JNSPG website👇
thejns.org/page/call-for-pap…
How can intraventricular endoscopy enhance the diagnosis and multidisciplinary management of pineal and other CNS malignancies?
Join Dr. Mark Souweidane for a focused discussion on the evolving role of endoscopic techniques in these challenging tumors. rebrand.ly/ms08122026
NS Tumor Section retweeted
🧠 NEW this year at #CNS2026 meeting ‼️ Join us Monday, 6-7pm for the first-ever Section Receptions
Drinks, snacks, and great company — connect with fellow neurosurgeons who share your interests.
Free for all CNS attendees. See you there! 🥂 @CNS_Update #network #Evolution
Applications are open for the AANS/CNS Joint Section on Tumors Resident Subcommittee.
Open to neurosurgery residents in good standing, including international residents.
🗓 Deadline: July 19, 2026 11:59 PM CT
🔗 tinyurl.com/TSRC2026
#Neurosurgery #NeuroOncology #TumorSection
Join Dr. Franz Ricklefs (Hamburg-Eppendorf) for the next #LatestHighlightsInNeurosurgicalOncology
📅 June 24 | 3:30 PM CST
🔗 aans-org.zoom.us/webinar/reg…
#Neurosurgery #Glioma #NeuroOncology #Methylation #PrecisionMedicine #BrainTumor #AANS #CNS





















